Question-and-Answer Session
Operator
(Operator Instructions) Your first question comes from Matt Miksic from Piper Jaffray.
Matt Miksic - Piper Jaffray
I am just wondering about the orthopedic business OUS. You talked about the stocking impact again this quarter, maybe offset by Japan. As you may have noticed the rest of the group was pretty weak and you are up in the corner. I am wondering if you can give us some color between Japan and Europe, whether what you saw was similar to what the markets saw, if you felt you did a little better than that.
Gary Henley
I think I would probably characterize it as about the same as the rest of the industry saw in Europe. We had some strong points. We continued the turn around we’ve experienced in Italy and we are continuing to make good progress there. So, I would say it is pretty much the same in the European theater. In Japan we continue to do very well there. I would tell you we were impacted a little bit with the swine flu scare there; maybe more there than other parts of the world, but all in all the Japanese business continues to be one of the highlights for us.
Matt Miksic - Piper Jaffray
In line in Europe would be sort of down year-over-year constant currency offset by better in Japan, is that fair to say?
Gary Henley
Yes. You know our Asian Pacific, Japan and Latin American business was all probably a little bit up compared to the European theater just slightly.
Matt Miksic - Piper Jaffray
Okay and one follow up on the P&L. Everyone is pleased to see the leverage in the SG&A line, but heading into the fourth quarter, I don’t know if I’m looking at this right, but does it look like there will be some significant improvement in bottom line performance, so you are stepping up from Q4 from the guidance you have given us in Q3 to Q4 John?
John Bakewell
No, I don’t believe so Matt and there again we haven’t offered up any quarterly guidance for Q4 yet. Our most recent quarter that we have broken out for you was Q2, so we are in the process of rolling through the year and kind of putting the finer point, I guess, on the quarters that are in the back end of the year. But, I don’t think we are planning on any kind of an improvement in Q4 versus the guidance that was maybe implied in our April call.
- To read the full transcript on Seeking Alpha, click here »
